DBL-H-T (BRS-02) is a long acting research peptide used to study two gut hormone receptors, GIP and GLP-1. In plain terms, it lets labs observe how these signals work together at the receptor level and how that may relate to appetite pathways, stomach emptying, insulin release, and energy use in controlled models. Publications describe its structure, receptor selectivity, and common study designs; this listing is for educational and laboratory reference only and makes no medical or therapeutic claims.
All products are intended for in vitro or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.
** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.
Additional Resources:
· https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
· https://www.nejm.org/doi/full/10.1056/NEJMoa2107519
· https://link.springer.com/article/10.1007/s13300-025-01804-w
· https://pi.lilly.com/us/zepbound-uspi.pdf
· https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806Orig1s020lbl.pdf